Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M A Johnson

Showing results (491-500 of 540) with videos related to

Pageof 54
Sort By:
Clinicoeconomics and Outcomes Research : CEOR|March 19, 2026
Real-World Treatment Patterns of Elranatamab in Patients with Multiple Myeloma in Japan: The EVEREST StudySatoshi Yoshihara, Aster Meche, Patrick Hlavacek, et al.
Arthritis and Rheumatism|June 1, 1992
Phenotypic and functional similarities between 5-azacytidine-treated T cells and a T cell subset in patients with active systemic lupus erythematosusB C Richardson, J R Strahler, T S Pivirotto, et al.
AIDS (London, England)|February 24, 2001
Reasons for modification and discontinuation of antiretrovirals: results from a single treatment centreA Mocroft, M Youle, A Moore, et al.
Nature|January 11, 1990
Very mild muscular dystrophy associated with the deletion of 46% of dystrophinS B England, L V Nicholson, M A Johnson, et al.
The Journal of Infectious Diseases|October 21, 1998
Pharmacokinetics and antiretroviral activity of lamivudine alone or when coadministered with zidovudine in human immunodeficiency virus type 1-infected pregnant women and their offspringJ Moodley, D Moodley, K Pillay, et al.
AJR. American Journal of Roentgenology|November 1, 1983
Clinical NMR imaging of the brain in children: normal and neurologic diseaseM A Johnson, J M Pennock, G M Bydder, et al.
Thorax|July 18, 2006
Adverse events and treatment interruption in tuberculosis patients with and without HIV co-infectionR A M Breen, R F Miller, T Gorsuch, et al.
Journal of Medical Genetics|September 1, 1993
Integrated study of 100 patients with Xp21 linked muscular dystrophy using clinical, genetic, immunochemical, and histopathological data. Part 1. Trends across the clinical groupsL V Nicholson, M A Johnson, K M Bushby, et al.
Journal of the Neurological Sciences|November 1, 1988
Cytochrome oxidase deficiency: immunological studies of skeletal muscle mitochondrial fractionsI M Shepherd, M A Birch-Machin, M A Johnson, et al.
Journal of the Neurological Sciences|August 1, 1983
Fatal infantile mitochondrial myopathy due to cytochrome c oxidase deficiencyP E Minchom, R L Dormer, I A Hughes, et al.
Pageof 54

Showing results (491-500 of 540) with videos related to

Sort By:
Pageof 54
Clinicoeconomics and Outcomes Research : CEOR|March 19, 2026
Real-World Treatment Patterns of Elranatamab in Patients with Multiple Myeloma in Japan: The EVEREST StudySatoshi Yoshihara, Aster Meche, Patrick Hlavacek, et al.
Arthritis and Rheumatism|June 1, 1992
Phenotypic and functional similarities between 5-azacytidine-treated T cells and a T cell subset in patients with active systemic lupus erythematosusB C Richardson, J R Strahler, T S Pivirotto, et al.
AIDS (London, England)|February 24, 2001
Reasons for modification and discontinuation of antiretrovirals: results from a single treatment centreA Mocroft, M Youle, A Moore, et al.
Nature|January 11, 1990
Very mild muscular dystrophy associated with the deletion of 46% of dystrophinS B England, L V Nicholson, M A Johnson, et al.
The Journal of Infectious Diseases|October 21, 1998
Pharmacokinetics and antiretroviral activity of lamivudine alone or when coadministered with zidovudine in human immunodeficiency virus type 1-infected pregnant women and their offspringJ Moodley, D Moodley, K Pillay, et al.
AJR. American Journal of Roentgenology|November 1, 1983
Clinical NMR imaging of the brain in children: normal and neurologic diseaseM A Johnson, J M Pennock, G M Bydder, et al.
Thorax|July 18, 2006
Adverse events and treatment interruption in tuberculosis patients with and without HIV co-infectionR A M Breen, R F Miller, T Gorsuch, et al.
Journal of Medical Genetics|September 1, 1993
Integrated study of 100 patients with Xp21 linked muscular dystrophy using clinical, genetic, immunochemical, and histopathological data. Part 1. Trends across the clinical groupsL V Nicholson, M A Johnson, K M Bushby, et al.
Journal of the Neurological Sciences|November 1, 1988
Cytochrome oxidase deficiency: immunological studies of skeletal muscle mitochondrial fractionsI M Shepherd, M A Birch-Machin, M A Johnson, et al.
Journal of the Neurological Sciences|August 1, 1983
Fatal infantile mitochondrial myopathy due to cytochrome c oxidase deficiencyP E Minchom, R L Dormer, I A Hughes, et al.
Pageof 54